TOLEDO, Ohio--(BUSINESS WIRE)--NAMSA, the world’s only Medical Research Organization (MRO), is pleased to announce the expansion of its global MRO Summit series. NAMSA’s MRO Summits will now offer further, complimentary educational events for medical device professionals wishing to gain direct access to consulting, testing and clinical resources worldwide.
During its 50 year history, NAMSA has supported thousands of clients throughout all stages of the medical device development lifecycle, and has established a successful track record of accelerating time-to-market and reducing costs associated with clinical research and market approval.
“The expansion of our MRO Summit series will allow us to share our global knowledge and scientific expertise on a wider scale by offering unique, real-world learning opportunities presented by NAMSA’s industry experts,” commented Christopher Rupp, NAMSA’s Director of Global Marketing. “We are extremely excited to present our shared experiences surrounding efficient medical device development, and to offer unique networking opportunities that allow medical device professional’s direct access to NAMSA’s knowledgeable, experienced thought leaders.”
With over 15 events throughout 2017, attendees can expect to gain knowledge regarding best practices and suggested strategies for medical device development success across the following areas:
- Regulatory Strategy
- Clinical Research
- Microbiology Testing & Validation
- Material and Chemical Characterization
- Biological Risk Assessment
- Preclinical Studies and Bioskills Training
To learn more about the MRO Summit series, with programs offered throughout the Americas, Asia and Europe – or to register – please visit the NAMSA website by clicking here.
We also invite you to learn more about how NAMSA is assisting medical device clients to enhance patient safety and improve healthcare worldwide by contacting us at: clientcare@namsa.com.
About NAMSA
NAMSA is a Medical Research Organization (MRO), accelerating medical device product development through integrated laboratory, clinical and consulting services. Driven by our regulatory expertise, NAMSA’s MRO® Approach plays an important role in translational research, applying a unique combination of disciplines – consulting, regulatory, preclinical, toxicology, microbiology, chemistry, clinical and quality – to move clients’ products through the development process, and continue to provide support through commercialization to post-market requirements, anywhere in the world.
Follow us on Twitter, LinkedIn or Facebook for regular updates.
